Brinton R D, Gonzalez T M, Cheung W S
Department of Molecular Pharmacology and Toxicology, University of Southern California, Los Angeles 90033, USA.
Brain Res. 1994 Dec 19;667(1):151-9. doi: 10.1016/0006-8993(94)91728-0.
We recently demonstrated that the neural peptide vasopressin (AVP) can act as a neurotrophic factor for hippocampal nerve cells in culture. Because the neurotrophic effect of vasopressin is mediated by the V1 receptor [11], we investigated AVP activation of calcium signaling pathways in cultured hippocampal neurons. Results of this investigation demonstrate that exposure of cultured hippocampal neurons prelabeled with [3H]myo-inositol to vasopressin induced a significant accumulation of [3H]inositol-1-phosphate ([3H]IP1). The selective V1 vasopressin receptor agonist, [Phe2, Orn2]vasotocin, induced a significant accumulation of [3H]IP1 whereas a selective V2 vasopressin receptor agonist, [deamino1, D-Arg8]-vasopressin, did not. Moreover, V1 agonist-induced accumulation of [3H]IP1 was blocked by the selective V1 vasopressin receptor antagonist d(CH2)5[Tyr(Me)2]-vasopressin. V1 agonist-induced accumulation of [3H]IP1 was concentration dependent and exhibited a steep inverted U-shaped curve that included both stimulation and inhibition of [3H]IP1 accumulation. Time course analysis of V1 agonist-induced accumulation of [3H]IP1 revealed significant increase by 20 min which continued to be significantly elevated for 60 min. Investigation of the effect of closely related peptides on [3H]IP1 accumulation indicated that the vasopressin metabolite peptide AVP4-9 and oxytocin significantly increased [3H]IP1 accumulation whereas the vasopressin metabolite peptide AVP4-8 did not. AVP4-9 and oxytocin induced [3H]IP1 accumulation were blocked by the V1 vasopressin receptor antagonist d(CH2)5[Tyr(Me)2]-vasopressin. V1 receptor activation was associated with a pronounced rise in intracellular calcium. Results of calcium fluorometry studies indicated that V1 agonist exposure induced a marked and sustained rise in intracellular calcium that exhibited oscillations.(ABSTRACT TRUNCATED AT 250 WORDS)
我们最近证明,神经肽血管加压素(AVP)可作为培养的海马神经细胞的神经营养因子。由于血管加压素的神经营养作用是由V1受体介导的[11],我们研究了AVP对培养的海马神经元钙信号通路的激活作用。这项研究结果表明,用[3H]肌醇预标记的培养海马神经元暴露于血管加压素后,诱导了[3H]肌醇-1-磷酸([3H]IP1)的显著积累。选择性V1血管加压素受体激动剂[Phe2, Orn2]血管紧张素能诱导[3H]IP1的显著积累,而选择性V2血管加压素受体激动剂[去氨基1, D-精氨酸8]-血管加压素则不能。此外,V1激动剂诱导的[3H]IP1积累被选择性V1血管加压素受体拮抗剂d(CH2)5[Tyr(Me)2]-血管加压素阻断。V1激动剂诱导的[3H]IP1积累呈浓度依赖性,呈现出一条陡峭的倒U形曲线,包括对[3H]IP1积累的刺激和抑制。对V1激动剂诱导的[3H]IP1积累的时间进程分析显示,20分钟时显著增加,并在60分钟内持续显著升高。对密切相关肽对[3H]IP1积累影响的研究表明,血管加压素代谢产物肽AVP4-9和催产素显著增加了[3H]IP1的积累,而血管加压素代谢产物肽AVP4-8则没有。AVP4-9和催产素诱导的[3H]IP1积累被V1血管加压素受体拮抗剂d(CH2)5[Tyr(Me)2]-血管加压素阻断。V1受体激活与细胞内钙的显著升高有关。钙荧光测定研究结果表明,暴露于V1激动剂会导致细胞内钙显著且持续升高,并呈现出振荡。(摘要截短于250字)